The DOI matches its Crossref record.
Hypertriglyceridemic Waist: A Marker of the Atherogenic Metabolic Triad (Hyperinsulinemia; Hyperapolipoprotein B; Small, Dense LDL) in Men?
Abstract
Background —The present study tested the hypothesis that simple variables, such as waist circumference and fasting plasma triglyceride (TG) concentrations, could be used as screening tools for the identification of men characterized by a metabolic triad of nontraditional risk factors (elevated insulin and apolipoprotein [apo] B and small, dense LDL particles). Methods and Results —Results of the metabolic study (study 1) conducted on 185 healthy men indicate that a large proportion (>80%) of men with waist circumference values ≥90 cm and with elevated TG levels (≥2.0 mmol/L) were characterized by the atherogenic metabolic triad. Validation of the model in an angiographic study (study 2) on a sample of 287 men with and without coronary artery disease (CAD) revealed that only men with both elevated waist and TG levels were at increased risk of CAD (odds ratio of 3.6, P <0.03) compared with men with low waist and TG levels. Conclusions —It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting TG could be used as inexpensive screening tools to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apo B, small, dense LDL) and at high risk for CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adding biochemical markers, such as plasma triglyceride levels, to the measurement of waist circumference—a phenotype described as hypertriglyceridaemic waist—has been suggested as a useful method for identification of individuals with excess visceral adipose tissue and ectopic fat.51”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [51]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1073/pnas.77.1.604 · DOI
- 10.1161/circ.94.3.273 · DOI
- 10.1136/hrt.71.3.293 · DOI
- 10.1056/NEJM199604113341504 · DOI · Paper page
- 10.1161/atv91.12.2.1543692 · DOI
- 10.1161/circ.95.1.69 · DOI
- 10.1001/jama.279.24.1955 · DOI
- 10.2337/diab.41.7.826 · DOI
- 10.1016/0002-9149(94)90676-9 · DOI
- 10.2337/diacare.19.6.629 · DOI · Paper page
- 10.1093/clinchem/28.10.2077 · DOI
- 10.1093/clinchem/20.4.470 · DOI
- 10.1172/JCI103182 · DOI
- 10.1016/0009-8981(60)90075-9 · DOI
- 10.1016/0003-2697(66)90246-6 · DOI
- 10.1016/0026-0495(87)90183-1 · DOI
- 10.1210/jcem-33-5-732 · DOI
- Standardization of anthropometric measurements. In: Lohman T Roche A Martorel R eds. The Airlie (VA) Consensus Conference. Champaign Ill: Human Kinetics; 1988:39–80.
- 10.1079/BJN19890104 · DOI
- 10.1016/S0002-9149(98)00328-2 · DOI
- 10.1161/circ.97.9.871 · DOI
- 10.1016/0009-8981(87)90188-4 · DOI
- 10.1093/clinchem/28.6.1379 · DOI
- 10.1093/clinchem/18.6.499 · DOI · Paper page
- 10.1161/atv91.12.11.1420088 · DOI
- 10.1161/01.CIR.85.1.37 · DOI · Paper page
- 10.1079/NRR19930010 · DOI
- 10.1016/S0140-6736(94)90814-1 · DOI
Cited by
Sorted by citations
Items 401–500 of 819
Udell, J. A., Steg, P. G., Scirica, B. M., Eagle, K. A., Ohman, E. M., Goto, S., Alsheikh-Ali, A. A. A., Porath, A., Corbalan, R. L., Umez-Eronini, A. A., et al. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313500541 · Cited by 20
Trajectories of Metabolic Syndrome Development in Young Adults
Poon, V. T. W., Kuk, J. L., & Ardern, C. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111647 · Cited by 21
Abdominal obesity, insulin resistance, metabolic syndrome and cholesterol homeostasis
Taverne, F. J., Richard, C., Couture, P., & Lamarche, B. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2013.07.003 · Cited by 23
Self-citationAssociation of estrogen receptor alpha gene polymorphisms with metabolic syndrome in Egyptian women.
Ghattas, M., Mehanna, E., Mesbah, N., & Abo-elmatty, D. (2013) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2013.05.014 · Cited by 20
Blouin, M., Binet, M., Bouchard, R., Roy, M., Despres, J., & Alméras, N. (2009) · Canadian journal of psychiatry. Revue canadienne de psychiatrie · doi:10.1177/070674370905400409 · Cited by 20
Self-citationRozkłady centylowe obwodu pasa u dzieci i młodzieży
Nawarycz, T., & Ostrowska-Nawarycz, L. (2007) · Pediatria Polska · doi:10.1016/s0031-3939(07)70387-6 · Cited by 16
Sénéchal, M., Lemieux, I., Beucler, I., Drobinski, G., Cormont, S., Dubois, M., Gandjbakhch, I., Després, J., & Dorent, R. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.05.009 · Cited by 18
Self-citationMoon, B., Park, H.-J., Lee, M.-K., Jeon, W. S., Park, S. E., Park, C.-Y., Lee, W., Oh, K., Park, S.-W., & Rhee, E. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.104 · Cited by 19
Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity
Onat, A., Dönmez, İ., Karadeniz, Y., Çakır, H., & Kaya, A. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.910114 · Cited by 18
Li, Z., Deng, M. L., Tseng, C., & Heber, D. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0090 · Cited by 19
“Krauss et al. demonstrated that increased plasma TG and reduced HDL-C are key features of the metabolic syndrome and suggested smaller low-density lipoprotein (LDL) particles as a marker for insulin resistance, especially for subjects with low HDL and TG < 150 mg/dlL. 14,15 18 In the Quebec Cardiovascular Study, 18 Le…”
Rocha, P. M., Barata, J. T., Minderico, C. S., Silva, A., Teixeira, P., & Sardinha, L. (2011) · Journal of Lipids · doi:10.1155/2011/154672 · Cited by 19
“Hindawi Publishing Corporation Journal of Lipids Volume 2011, Article ID 154672, 11 pages doi:10.1155/2011/154672”
BackgroundInfluentialRosolová, H., & Nussbaumerová, B. (2011) · The EPMA Journal · doi:10.1007/s13167-011-0066-1 · Cited by 20
“Several groups have reported that an increase in waist circumference and fasting TG levels (described as the hypertriglyceridemic waist) may be relevant and readily screened measures to identify subjects at high risk of MS [16].”
BackgroundPannier, B., Thomas, F., Bean, K., Jégo, B., Benetos, A., & Guize, L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282fd9936 · Cited by 19
Kojima, M., Kanno, H., Yamazaki, Y., Koyama, S., Kanazawa, S., & Arisaka, O. (2005) · Acta paediatrica · doi:10.1111/j.1651-2227.2005.tb03070.x · Cited by 19
Lin, Z.-Y., Yuan, S., Li, B.-W., Guan, J., He, J.-N., Song, C.-X., Li, J., & Dou, K. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101566 · Cited by 18
Lee, B. J., & Kim, J. Y. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0510-0 · Cited by 17
Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
Rhee, E. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.19 · Cited by 15
“Hypertriglyceridemic waist (HTGW) phenotype is a recently recommended concept that reflects those with high risk for CVD and also those with metabolically unhealthiness [36].”
BackgroundLwow, F., Jędrzejuk, D., Milewicz, A., & Szmigiero, L. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.06.007 · Cited by 18
Cintura hipertrigliceridémica en adultos jóvenes en el sur de Brasil
Haack, R., Horta, B., Gigante, D., Barros, F., Oliveira, I., & da Silveira, V. M. F. (2013) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2013000500017 · Cited by 18
da Rocha, N. P., Siqueira-Catania, A., de Barros, C. R., Monfort‐Pires, M., Folchetti, L. D., & Ferreira, S. R. G. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000700008 · Cited by 14
Andrea Valenzuela, B., Alberto Maiz, G., Margozzini, P., Catterina Ferreccio, R., Rigotti, A., Olea, R., & Arteaga, A. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000600007 · Cited by 21
“En nuestro estudio la prevalencia de SM fue 31,6% (IC 95% 28,5-34,9) para el criterio diagnóstico ATPIII actualizado y 36,8% (33,5-40,3) para el criterio IDF (Figura 1).”
BackgroundThe Treatment of Dyslipidemia—What's Left in the Pipeline?
Rau, O., Zettl, H., Popescu, L. N., Steinhilber, D., & Schubert‐Zsilavecz, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200700165 · Cited by 17
Ybarra, J., Sánchez-Hernández, J., Pou, J. M., Fernández, S., Gich, I. J., Ordóñez‐Llanos, J., Jurado, J., de Leiva, A., & Pérez, A. (2005) · Global Heart · doi:10.1016/j.precon.2005.05.001 · Cited by 13
Onat, A., Ceyhan, K., Sansoy, V., Başar, O., Erer, B., Uysal, O., & Hergenç, G. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00190-0 · Cited by 18
Risk factor management after short-term versus long-term cardiac rehabilitation program
Boulay, P., & Prud'homme, D. (2001) · Coronary Health Care · doi:10.1054/chec.2001.0127 · Cited by 18
Self-citationTratamiento de la hipertrigliceridemia: fibratos frente a ácidos grasos omega-3
Ros, E., & Laguna, J. C. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)74826-9 · Cited by 9
Scarsella, C., & Després, J. (2003) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2003000700002 · Cited by 35
“…de las HDL en estos pacientes visceralmente obesos, representa el principal factor responsable del aumento de la relación colesterol total/HDL-colesterol (Lemieux et al., 2000), siendo esta relación un potente indicador predictivo de riesgo de la enfermedad coronaria (Figura 3) (Castelli, 1984).”
BackgroundInfluentialTorun, C., Ankarali, H., Castur, L., Uzunlulu, M., Erbakan, A., Akbaş, M. M., Gündüz, N., Doğan, M., Bahadir, M. A., & Oğuz, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1411678 · Cited by 17
Dikobo, S. J. E., Lemieux, I., Poirier, P., Després, J., & Alméras, N. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.12.005 · Cited by 21
Self-citationGuscoth, L. B., Appleton, S., Martin, S., Adams, R., Melaku, Y. A., & Wittert, G. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s327478 · Cited by 37
Carter, S., Lemieux, I., Li, Z., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Després, J., & Picard, F. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.016 · Cited by 18
Self-citationInsulin resistance, metabolic syndrome, and lipids in African women.
Young, E., Okafor, C., Iroezindu, M., & Agbalu, I. (2016) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.183242 · Cited by 17
“This is because HDL particles participate in the clearance of TG‐rich lipid particles.[10] Hence, when TG levels are high, HDL levels are expected to be low and vice‐versa.”
BackgroundBrown, J. C., Harhay, M. O., & Harhay, M. N. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1308-8 · Cited by 18
“Another metric, the hyper-triglyceridemic waist, defined as the cooccurrence of a large WC and elevated fasting triglyceride concentration, is predictive of excess VAT [32].”
BackgroundBuchan, D. S., Boddy, L. M., Després, J., Grace, F., Sculthorpe, N. F., Mahoney, C. J., & Baker, J. S. (2015) · Pediatric Obesity · doi:10.1111/ijpo.12061 · Cited by 19
“Excessive abdominal obesity is regularly cited as a key mediator of cardiometabolic dysfunction given its association with cardiometabolic risk and mortality (2).”
BackgroundSelf-citationLesser, I., Guenette, J., Hoogbruin, A., Mackey, D., Singer, J., Gasevic, D., & Lear, S. (2016) · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · doi:10.1139/apnm-2016-0082 · Cited by 17
Visceral adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America
Wimalawansa, S. J. (2013) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s32041 · Cited by 17
“Phenotypes with excess intra-abdominal fat are referred to as the hypertriglyceridemic waist.(96) Moreover, the quantity of visceral fat explains the positive association between the visceral fat (thus, WC) and morbidity.”
McCourt, H. J., Hunter, S., Cardwell, C., Young, I. S., Murray, L., Boreham, C., McEneny, J., Woodside, J., & McKinley, M. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.214 · Cited by 17
Snehalatha, C., Nanditha, A., Shetty, A. S., & Ramachandran, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.07.016 · Cited by 12
Koh, J., Koh, S., Lee, M.-Y., Jung, P. M., Kim, B. H., Shin, J., Shin, Y., Ryu, S., Lee, T., Park, J. K., et al. (2010) · Journal of Korean medical science · doi:10.3346/jkms.2010.25.5.734 · Cited by 17
“Although the cause of the syndrome remains obscure, insulin resistance and visceral obesity were considered as central factor (1, 11).”
BackgroundGoday, A., Gabriel, R., Ascaso, J. F., Franch, J., Ortega, R., Martínez, O., & Lerones, N. (2008) · Revista Clínica Española · doi:10.1157/13126339 · Cited by 15
Corica, F., Corsonello, A., Lucchetti, M., Malara, A., Domenico, D. D., Cannavò, L., Foti, S., Valenti, A., Ientile, R., & Saitta, A. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803476 · Cited by 14
Zheng, X., Ren, X.-L., Jiang, M.-J., & Han, L.-Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.940168 · Cited by 16
von Korn, P., Keating, S. E., Mueller, S., Haller, B., Kränkel, N., Dinges, S. M.-T., Duvinage, A., Scherr, J., Wisløff, U., Tjønna, A. E., et al. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0105 · Cited by 18
“13 Anthropometric indices that extend WC by other metabolic or anthropometric variables such as TAG ( i.e. , HTW phenotype) 21,22,24 or height ( i.e. , waist-to-height-ratio) 18–20 have been shown to refine phenotypic screening and thus have the potential to improve risk stratification.”
Cibičková, Ľ., Langová, K., Vaverkova, H., Lukeš, J., Cibiček, N., & Karásek, D. (2019) · Physiological Research · doi:10.33549/physiolres.934176 · Cited by 16
Tian, Y.-M., Ma, N., Jia, X.-J., & Lu, Q. (2019) · Eating and Weight Disorders · doi:10.1007/s40519-019-00677-w · Cited by 16
HYPERTRIGLYCERIDEMIC WAIST PHENOTYPE AND CARDIOMETABOLIC ALTERATIONS IN BRAZILIAN ADULTS.
da Rocha, A. L. C., Pereira, P. F., Pessoa, M. C., Alfenas, R. D. C. G., Segheto, W., da Silva, D. C. G., de Andrade, M. P., & Longo, G. Z. (2015) · PubMed · doi:10.3305/nh.2015.32.3.9305 · Cited by 19
Testosterone Supplementation Therapy in the Treatment of Patients with Metabolic Syndrome
Kovac, J. R., Pastuszak, A. W., Lamb, D. J., & Lipshultz, L. I. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.11.2843 · Cited by 18
Zhe, X., Bai, Y., Cheng, Y., Xiao, H., Wang, D., Wu, Y. Y., Huang, X., Tian, X.-K., & Wang, T. (2013) · Nephron Clinical Practice · doi:10.1159/000351042 · Cited by 17
Samadi, S., Bozorgmanesh, M., Khalili, D., Momenan, A., Sheikholeslami, F., Azizi, F., & Hadaegh, F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.049 · Cited by 16
Bardini, G., Dicembrini, I., Pala, L., Cresci, B., & Rotella, C. M. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03332.x · Cited by 15
Lahiry, P., Cao, H., Ban, M. R., Pollex, R. L., Mamakeesick, M., Zinman, B., Harris, S. B., Hanley, A. J., Huff, M. W., Connelly, P. W., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p002014 · Cited by 14
Chinese Metabolic Syndrome Risk Score
Hsiao, F., Wu, C., Hsieh, C., He, C., Hung, Y.-J., & Pei, D. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e3181836b19 · Cited by 17
“Després et al further proposed the term “hypertriglyceridemic waist” to emphasize the increasing predictive value in cardiovascular diseases after considering TG and WC together.(22,23) There are some limitations in our study.”
BackgroundWhyte, M., Shojaee‐Moradie, F., Sharaf, S. E., Cuthbertson, D. J., Kemp, G. J., Barrett, M. G., Jackson, N. C., Herring, R. A., Wright, J., Thomas, E. L., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00019.2020 · Cited by 21
“Previous studies have shown the activity of hepatic lipase to be increased in 346 obese men (26; 34) and women (6; 9) with high intra-abdominal fat levels.”
BackgroundGharipour, M., Sadeghi, M., Nezafati, P., Dianatkhah, M., & Sarrafzadegan, N. (2019) · Journal of research in health sciences · doi:10.34172/jrhs194746 · Cited by 15
Poirier, J., Kubow, S., Noël, M., Dupont, C., & Egeland, G. M. (2015) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.09.004 · Cited by 15
Targeting Abdominal Adiposity and Cardiorespiratory Fitness in the Workplace.
Lévesque, V., Vallières, M., Poirier, P., Despres, J., & Alméras, N. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000559 · Cited by 15
Self-citationZubair, N., Mayer-Davis, E., Mendez, M., Mohlke, K., North, K., & Adair, L. (2014) · Nutrition & Diabetes · doi:10.1038/nutd.2014.16 · Cited by 15
Hobkirk, J., King, R., Gately, P., Pemberton, P., Smith, A. C., Barth, J., Harman, N., Davies, I., & Carroll, S. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0152 · Cited by 15
“The HyperTG waist has previously been shown to predict the metabolic triad with high ( > 80%) sensitivity and specificity in middle-aged adults.(5) However, the HyperTG waist and the metabolic triad have not been previously investigated in obese youth, especially in response to weight loss.”
L’obésité abdominale : une menace pour la santé
Bruckert, É. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2008.01.021 · Cited by 11
Moreno, B., & Casanueva, F. F. (2007) · Medicina Clínica · doi:10.1157/13100347 · Cited by 17
2nd International Symposium on Triglycerides and HDL
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2577 · Cited by 9
Ali, Z., Ma, H., Rashid, M. T., Ayim, I., & Wali, A. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12554 · Cited by 14
Singh, R. B., Fedacko, J., Saboo, B., Niaz, M., Maheshwari, A., Verma, N., & Bharadwaj, K. (2017) · MOJ Public Health · doi:10.15406/mojph.2017.06.00193 · Cited by 14
Ramezankhani, A., Azizi, F., Ghanbarian, A., Parizadeh, D., & Hadaegh, F. (2017) · Obesity Research and Clinical Practice · doi:10.1016/j.orcp.2016.11.003 · Cited by 14
Costa, P. R. D. F., Assis, A. M., Cunha, C. D. M., Pereira, E. M., dos Santos, D. J. G., da Silva, L. E. M., & Alves, W. P. D. O. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170067 · Cited by 14
“– 3o Tercil 492 206 (94,1) 13 (5,9) 0,003* – 1o e 2o Tercis 234 (85,7) 39 (14,3)”
BackgroundInfluentialClustering of chronic kidney disease and cardiovascular risk factors in South-West Nigeria
Oluyombo, R., Olamoyegun, M., Ayodele, O., Akinwusi, P., & Akinsola, A. (2017) · Journal of Nephropathology · doi:10.15171/jnp.2017.33 · Cited by 14
Larifla, L., Rambhojan, C., Joannes, M.-O., Maimaitiming-Madani, S., Donnet, J., Marianne-Pépin, T., Chout, R., Roussel, R., & Foucan, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163421 · Cited by 14
Kelishadi, R., Jamshidi, F., Qorbani, M., Motlagh, M., Heshmat, R., Ardalan, G., & Hovsepian, S. (2016) · Jornal de Pediatria · doi:10.1016/j.jped.2015.12.009 · Cited by 14
Byun, A., Kwon, S.-W., Lee, S. W., Shim, K., & Lee, H.-S. (2016) · Medicine · doi:10.1097/md.0000000000003902 · Cited by 14
“A previous study mentioned the “hypertriglyceridemic waist,” which means a phenotypewho had an excessive visceral adipose tissue, increased waist circumference, and elevated plasma triglyceride levels.([26]) Another study also suggested that the percentage of visceral adipose tissue has to be regarded as a risk factor…”
Prevention of Atherosclerotic Cardiovascular Disease
Daniels, S. R. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.082 · Cited by 11
Hypertriglyceridemic waist and newly-diagnosed diabetes among remote-dwelling Indigenous Australians
Daniel, M., Paquet, C., Kelly, S., Zang, G., Rowley, K., McDermott, R., & O'Dea, K. (2013) · Annals of Human Biology · doi:10.3109/03014460.2013.806588 · Cited by 14
“Canadian researchers examined the relationship between HTgW and T2DM diagnosed with an oral glucose tolerance test (OGTT) in Inuit Indigenous people not previously known to have T2DM (Egeland et al., 2011).”
ResultPredicting cardiovascular risk using measures of regional and total body fat.
Ricciardi, R., Metter, E. J., Cavanaugh, E., Ghambaryan, A., & Talbot, L. (2009) · Applied Nursing Research · doi:10.1016/j.apnr.2007.01.011 · Cited by 14
Brisson, D., St-Pierre, J., Santuré, M., Hudson, T., Despres, J., Vohl, M., & Gaudet, D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803586 · Cited by 14
Self-citationHansel, B., Kontush, A., Giral, P., Bonnefont‐Rousselot, D., Chapman, M. J., & Bruckert, É. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104821 · Cited by 13
Desjardins, L.-C., Brière, F., Tremblay, A. J., Rancourt-Bouchard, M., Drouin‐Chartier, J., Corbeil, J., Lemelin, V., Charest, A., Schaefer, E. J., Lamarche, B., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.03.015 · Cited by 15
Self-citationXuan, Y., Shen, Y., Wang, S., Gao, P., Gu, X., Tang, D., Wang, X., Zhu, F., Lu, L., & Chen, L. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14424 · Cited by 13
Hwang, K., Han, K., Oh, S., Koo, B. K., Lee, S. K., Kim, J.-J., Seo, H. J., Jung, J., Kim, B. H., & Hur, H. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0300 · Cited by 18
Qiu, Y., Zhao, Q., Gu, Y., Wang, N., Yu, Y.-T., Wang, R.-P., Zhang, Y., Cui, S.-H., Zhu, M.-Y., Liu, X., et al. (2020) · Nutrition and Metabolism · doi:10.1186/s12986-020-00483-7 · Cited by 13
Longo, M., Alrais, M. A., Tamayo, E., Ferrari, F., Facchinetti, F., Refuerzo, J. S., Blackwell, S., & Sibai, B. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.11.1101 · Cited by 13
Wang, W., Shen, C., Zhao, H., Tang, W., Yang, S., Li, J., Ren, Z., & Zhao, Y. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12925 · Cited by 13
Barreiro-Ribeiro, F., Vasques, A., da Silva, C. D. C., Zambon, M., Rodrigues, A. M. D. B., Camilo, D. F., Antônio, M. Â. R. D. G. M., Dâmaso, A., Campos, R. M. D. S., Tufik, S., et al. (2016) · Childhood Obesity · doi:10.1089/chi.2016.0180 · Cited by 13
Sluik, D., Brouwer-Brolsma, E., de Vries, J., Geelen, A., & Feskens, E. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010437 · Cited by 13
Das, S., Datta, A., Bagchi, C., Chakraborty, S., Mitra, A., & Tripathi, S. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2015.1118654 · Cited by 13
“A triad hyperinsulinemia, increased levels of apo B and small dense LDL particles can increase the risk of cardiovascular disease by up to 20 times (Lemieux et al., 2000).”
BackgroundDesprés, J. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.04.043 · Cited by 13
Self-citationFerrara, M., Umlauf, A., Sanders, C., Meyer, J. M., McCutchan, J. A., Duarte, N. A., Atkinson, J. H., Grant, I., & Ellis, R. J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.015 · Cited by 17
“…triglycerides and DM. Additionally, TC and TG values were also analyzed on a dichotomized scale based on the most recent guidelines for risk ranges: TC ≥ 200 mg/dL, HDL < 40 mg/dL, LDL ≥ 130 mg/dL, TC/HDL ≥ 5, TG ≥ 150 mg/dL (Blackburn et al., 2008; Lemieux et al., 2000; Mannucci et al., 2008).”
MethodAhmadpour, F. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.s1-019 · Cited by 12
Madeira, I., Bordallo, M. A., Carvalho, C. N. M., Gazolla, F., de Souza, F. M., de Matos, H. D., & Borges, M. (2011) · Journal of Pediatric Endocrinology & Metabolism (JPEM) · doi:10.1515/jpem.2011.177 · Cited by 13
“Our hypothesis is that, besides the alterations in leptin and adiponectin levels, the conventional components of metabolic syndrome have an infl uence on the etiology of CVD since childhood, mainly in the group of children with insulin resistance.”
BackgroundInfluentialde Carvalho, É. H., Miranda-Filho, D. D. B., Ximenes, R. A. D. A., de Albuquerque, M. D. F. P. M., Lacerda, H. R., Gelenske, T., Barros, Z. D. M., Montarroyos, U. R., & Bandeira, F. A. F. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0092 · Cited by 12
Rostambeigi, N., Shaw, J., Atkins, R., Ghanbarian, A., Cameron, A., Forbes, A., Momenan, A., Hadaegh, F., Mirmiran, P., Zimmet, P., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.12.025 · Cited by 13
Candela, J. M., Nadal, J., Ortiz, J. R., Domínguez, C. C., Martín, A. G., & Pérez, M. (2006) · Atención Primaria · doi:10.1157/13090435 · Cited by 13
Arisaka, O., Kojima, M., Yamazaki, Y., Kanazawa, S., Koyama, S., Shimura, N., & Okada, T. (2004) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.11.220 · Cited by 13
Obésité et maladies cardiovasculaires
Poirier, P., & Després, J. (2003) · médecine/sciences · doi:10.1051/medsci/20031910943 · Cited by 21
Singh, M. A. F. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2001-3_31 · Cited by 12
Prevalence of non-communicable diseases risk factors in two groups of urban populations.
Mahajan, D., Birari, S., Khairnar, G., Patil, Y. P., Kadam, V., & Joshi, Y. (2009) · Asian Journal of Epidemiology · doi:10.3923/aje.2009.1.8 · Cited by 13
Zhang, C., Xu, R.-Q., Wang, X., Sun, L., Mo, P., Cai, R.-J., Lin, X., Luo, C.-F., Ou, W., Lu, L., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01942-0 · Cited by 13
“Isabelle and colleagues reported that elevated TG levels increased the risk of CAD in obese individuals with a WC > 90 cm (with an OR of 2.4) [8].”
BackgroundInfluentialLiu, J., Duan, S., Wang, C., Wang, Y., Peng, H.-Y., Niu, Z.-H., & Yao, S.-K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1035418 · Cited by 12
Bahadoran, Z., Mirmiran, P., Ghasemi, A., & Azizi, F. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.08.002 · Cited by 11
Sumner, A., Furtado, J., Courville, A., Ricks, M., Younger-Coleman, N., Tulloch-Reid, M., & Sacks, F. (2013) · Nutrition and Metabolism · doi:10.1186/1743-7075-10-73 · Cited by 12
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women
Gazi, I., Milionis, H., Filippatos, T., Tsimihodimos, V., Kostapanos, M., Doumas, M., Tselepis, A., & Elisaf, M. (2008) · Diabetes/Metabolism Research Reviews · doi:10.1002/dmrr.784 · Cited by 12
“The term ‘hypertriglyceridaemic waist’ (HTGW) phenotype was first used in the early 2000s to identify men with increased levels of fasting triglycerides (TG) (≥2 mmol/L, 180 mg/dL) and waist circumference ≥90 cm [1].”
BackgroundMethodGenetic Determinants of Risk Factors for Cardiovascular Disease in a Population from Rural Brazil
Velásquez-Meléndez, G., Parra, F. C., Gazzinelli, A., Williams‐Blangero, S., & Corrêa‐Oliveira, R. (2007) · Human Biology · doi:10.1353/hub.2007.0036 · Cited by 9
“For example, amount of abdominal fat tissue, dietary intake, and level of physical activity have all been shown to influence lipoprotein levels (Després et al. 1990; Lemieux et al. 2000).”
Background
Metadata
- Authors
- Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., Nadeau, A., & Després, J.-P.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- From the Quebec Heart Institute, Laval Hospital Research Center; the Lipid Research Center, CHUL Research Center; the Physical Activity Sciences Laboratory, Laval University; the Diabetes Research Unit, CHUL Research Center, Ste-Foy; and the Lipid Clinic, Chicoutimi Hospital, Chicoutimi, Québec, Canada.
- ORCID
- Venue
- Circulation
- Published
- 2000-07-11
- Volume
- 102
- Issue
- 2
- Pages
- 179-184
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991251155
- Cited by
- 937
- References
- 0
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 31 · 2021: 29 · 2020: 30 · 2019: 26 · 2018: 35 · 2017: 29 · 2016: 38 · 2015: 38 · 2014: 42 · 2013: 42 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Heart and Stroke Foundation of Canada
- Medical Research Council Canada
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hypertriglyceridemic waist phenotype, waist circumference, fasting plasma triglycerides, hyperinsulinemia, apolipoprotein B, small dense LDL, coronary artery disease risk, cardiovascular screening, men
- MeSH terms
- Abdomen, Adult, Apolipoproteins B, Body Composition, Coronary Artery Disease, Coronary Disease, Humans, Hyperinsulinism, Lipoproteins, LDL, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Hypertriglyceridemia, Biomarkers, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review